64
total announcements
JSLL.NS · 15 min delayed
Key Stats · Yahoo Finance · as of 15 Oct 2026
Market Cap
₹4,783 Cr
P/E (TTM)
20.3
P/E (Forward)
10.7
EPS (TTM)
₹18.98
52W Low
₹359.75
52W High
₹835.00
Dividend Yield
1.15%
Beta
1.04
Price / Book
10.2
Debt / Equity
27.3
Revenue (TTM)
₹851 Cr
Gross Margin
88.39%
Operating Margin
34.17%
Jeena Sikho Lifecare Limited
Jeena Sikho Lifecare Limited has informed the Exchange about Integrated Annual Report for Financial Year 2025-26 and the 9th Annual General Meeting to be held on September 28, 2026.
Jeena Sikho Lifecare Limited
Jeena Sikho Lifecare Limited has informed the Exchange regarding Notice of the 9th Annual General Meeting and Integrated Annual Report for Financial Year 2025-26.
Jeena Sikho Lifecare Limited
Jeena Sikho Lifecare Limited has informed the Exchange about the launch of new products, including Narie Xpert Granules, Narie Xpert Syrup, Narie Xpert Tablet, Porush Xpert Granules, Porush Xpert Syrup, and Porush Xpert Tablet, as part of its Ayurvedic, healthcare and wellness product portfolio.
Jeena Sikho Lifecare Limited
Jeena Sikho Lifecare Limited has informed the Exchange about Book Closure and Cut-off date for the 9th Annual General Meeting and determining entitlement to Final Dividend, if declared.
Jeena Sikho Lifecare Limited
Jeena Sikho Lifecare Limited has informed the Exchange that Record date for the purpose of Dividend is 21-Sep-2026. The company has also announced the 9th Annual General Meeting (AGM) on September 28, 2026, and the appointment of a Scrutinizer for the AGM.
Jeena Sikho Lifecare Limited
Jeena Sikho Lifecare Limited has informed the Exchange regarding Outcome of Board Meeting held on August 31, 2026. The Board considered and approved the Annual Report for the Financial Year 2025-2026, Fixation of Date of AGM and Notice of the 9th Annual General Meeting, Fixation of Dividend Record Date, Appointment of Scrutinizer for the Proposed 9th Annual General Meeting, and Book Closure and Cut-off date.
Jeena Sikho Lifecare Limited
Jeena Sikho Lifecare Limited has informed the Exchange about an Analyst / Investor meet under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, scheduled to be held on 03rd September, 2026.
Jeena Sikho Lifecare Limited
Jeena Sikho Lifecare Limited has informed the Exchange about the launch of nine new products as part of its Ayurvedic, healthcare and wellness product portfolio.
Jeena Sikho Lifecare Limited
Jeena Sikho Lifecare Limited has informed the Exchange about Analyst / Investor meet scheduled to be held on 31st August, 2026.
Jeena Sikho Lifecare Limited
Jeena Sikho Lifecare Limited has announced its Q1 FY27 financial results, with revenue from operations increasing 29% YoY to ₹224.4 crore. The company's private-pay Panchakarma hospitalisation, at-centre medicine sales, and digital/e-commerce medicine channel drove growth. The company has also provided an update on its IPD growth, business mix, and operating performance.
Jeena Sikho Lifecare Limited
Jeena Sikho Lifecare Limited has published case studies on Ayurvedic research and evidence-based clinical practice in a medical journal.
Jeena Sikho Lifecare Limited
Jeena Sikho Lifecare Limited has informed the Exchange about the publication of case studies authored by medical professionals associated with the company, including its Managing Director, in two international journals.
Jeena Sikho Lifecare Limited
Jeena Sikho Lifecare Limited has submitted the transcript of its Earnings Conference Call for Q1 FY27, which ended on June 30, 2026. The company discussed its business model, financial performance, and future prospects.
Jeena Sikho Lifecare Limited
Jeena Sikho Lifecare Limited has informed the Exchange about the proposal to establish a new Ayurvedic, Naturopathy and Panchkarma Hospital facility at Bareilly, Uttar Pradesh, as part of the Company's expansion strategy.
Jeena Sikho Lifecare Limited
Jeena Sikho Lifecare Limited has submitted the audio recording of its Q1 FY 2026-27 earnings conference call on its website.
Jeena Sikho Lifecare Limited
Jeena Sikho Lifecare Limited has made an investor presentation, details not specified.
Jeena Sikho Lifecare Limited
Jeena Sikho Lifecare Limited has submitted a copy of newspaper publication for the unaudited financial results for the quarter ended June 30, 2026.
Jeena Sikho Lifecare Limited
Jeena Sikho Lifecare Limited has announced the re-appointment of Mrs. Bhavna Grover as Whole-time Director, Mr. Karan Vir Bindra as Independent Director, and Mr. Manish Grover as Managing Director, subject to shareholder approval.
Jeena Sikho Lifecare Limited
Jeena Sikho Lifecare Limited has informed the Exchange regarding the re-appointment of Mr. Manish Grover as Managing Director of the company, subject to approval of the shareholders, along with the re-appointment of two other directors.
Jeena Sikho Lifecare Limited
Jeena Sikho Lifecare Limited has informed the Exchange regarding the appointment of Mr. Karan Vir Bindra as a Non-Executive Independent Director of the company, subject to approval of the shareholders.